论文部分内容阅读
目的观察思连康、思密达对新生儿母乳性黄疸的疗效。方法将符合诊断标准的63例患儿分为观察组和对照组。观察组32例是在常规治疗(服用鲁米那、维生素C)的基础上口服思连康、思密达,两组均服药7天,治疗前后抽血测定胆红素值。结果两组患儿的黄疸均有不同程度的减轻,但治疗组的疗效明显优于对照组,(P<0.001),差异有非常显著性。结论思连康、思密达联合治疗新生儿母乳性黄疸,疗效确切,方法简便,易被家长及患儿接受。无任何不良反应。
Objective To observe the effect of Si Lian Kang and Smecta on neonatal breast milk jaundice. Methods According to the diagnostic criteria of 63 cases were divided into observation group and control group. 32 cases in the observation group were treated with Si Lian Kang and Smectite orally on the basis of routine treatment (taking luminal, vitamin C). Both groups took medication for 7 days, and blood bilirubin values were measured before and after treatment. Results The jaundice in both groups were relieved to some extent, but the curative effect of the treatment group was obviously better than that of the control group (P <0.001). The difference was very significant. Conclusion Si Lian Kang, Smectite combination treatment of neonatal breast milk jaundice, curative effect is exact, the method is simple and easy to accept by parents and children. No adverse reactions.